Thomas Hogan Sells 25,299 Shares of Cellebrite DI (NASDAQ:CLBT) Stock

Cellebrite DI Ltd. (NASDAQ:CLBT) insider Thomas Hogan sold 25,299 shares of the firm’s stock in a transaction on Tuesday, August 25th. The stock was sold at an average price of $11.29, for a total transaction of $285,625.71. Following the transaction, the insider directly owned 765,249 shares of the company’s stock, valued at approximately $8,639,661.21. This trade represents a 3.20% decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink.

Cellebrite DI Stock Performance

NASDAQ:CLBT opened at $11.99 on Friday. Cellebrite DI Ltd. has a one year low of $9.58 and a one year high of $19.98. The firm has a market cap of $2.99 billion, a price-to-earnings ratio of 54.50, a PEG ratio of 1.88 and a beta of 1.18. The firm’s fifty day moving average is $14.16 and its two-hundred day moving average is $13.77.

Hedge Funds Weigh In On Cellebrite DI

Several hedge funds and other institutional investors have recently added to or reduced their stakes in the stock. California State Teachers Retirement System increased its stake in shares of Cellebrite DI by 1,595.2% during the second quarter. California State Teachers Retirement System now owns 1,972,752 shares of the company’s stock worth $28,802,000 after purchasing an additional 1,856,378 shares in the last quarter. Wellington Management Group LLP lifted its stake in Cellebrite DI by 93.7% in the 2nd quarter. Wellington Management Group LLP now owns 3,049,904 shares of the company’s stock valued at $44,529,000 after buying an additional 1,475,579 shares in the last quarter. Public Employees Retirement System of Ohio acquired a new stake in Cellebrite DI in the 2nd quarter worth about $454,000. Elevation Wealth Partners LLC acquired a new stake in Cellebrite DI in the 2nd quarter worth about $44,000. Finally, Moody National Bank Trust Division increased its stake in Cellebrite DI by 7.6% during the 2nd quarter. Moody National Bank Trust Division now owns 60,691 shares of the company’s stock worth $886,000 after buying an additional 4,284 shares in the last quarter. 45.88% of the stock is owned by hedge funds and other institutional investors.

Wall Street Analyst Weigh In

Several analysts recently commented on CLBT shares. Needham & Company LLC dropped their target price on Cellebrite DI from $15.00 to $12.50 and set a “buy” rating on the stock in a report on Friday, August 14th. DA Davidson lowered their price objective on Cellebrite DI from $22.00 to $15.00 and set a “buy” rating on the stock in a research report on Friday, August 14th. Lake Street Capital dropped their price objective on shares of Cellebrite DI from $21.00 to $15.00 and set a “buy” rating on the stock in a research note on Friday, August 14th. Weiss Ratings lowered shares of Cellebrite DI from a “hold (c-)” rating to a “sell (d+)” rating in a report on Thursday, August 13th. Finally, JPMorgan Chase & Co. decreased their target price on shares of Cellebrite DI from $20.00 to $16.00 and set an “overweight” rating for the company in a research note on Friday, August 14th. Five analysts have rated the stock with a Buy rating and one has given a Sell rating to the stock. Based on data from MarketBeat.com, the company presently has a consensus rating of “Moderate Buy” and a consensus price target of $16.70.

Cellebrite DI Company Profile

Cellebrite DI is a global provider of digital intelligence and forensics solutions that enable law enforcement agencies, government bodies and enterprises to extract, analyze and act on data from mobile devices, cloud services and digital sources. The company’s technology is designed to accelerate investigations, support evidence-based decision-making and enhance security operations by delivering actionable intelligence in a secure, scalable platform.

The company’s flagship offerings include the Universal Forensic Extraction Device (UFED) series for data acquisition and decoding, Physical Analyzer for advanced data parsing and visualization, and Pathfinder for case-driven investigation workflows.